Digital Health, Cybersecurity Would See Significant Chunk Of FDA Device-Funding Boost

 
• By Sue Darcey
  
Generate a summary of this article
Listen to this article
Beta

If Congress approves a 26% higher 2019 funding request for US FDA's device center, a substantial chunk of those dollars would go to building a novel framework for regulating digital-health technologies, and to help FDA and device manufacturers respond better to cybersecurity vulnerabilities, among other program priorities, according to agency officials.

Medical app

US FDA's Center for Devices and Radiological Health has big plans to use a proposed increase in funding – from $505m in 2018 to $636m in 2019 – to build a new digital health regulatory framework and enhance cybersecurity protection for devices. The funds would also go to support stepping up efforts to revamp how FDA assesses device manufacturing activities and how it leverages real-world data using the National Evaluation System for health Technology (NEST), according to FDA Commissioner Scott Gottlieb.

Earlier this week, the Trump administration proposed a $131m raise for the device center and a planned 17% increase for...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Legislation

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By Nabil

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Better Coverage For Cancer Screening Tests On Horizon

 
• By Elizabeth Orr

Multi-cancer diagnostics can help get oncology patients the treatment they need more quickly, but lack of reimbursement has kept such tests out of reach for many patients. Bills providing coverage have passed or are under consideration in more than half of the states and have been introduced in both houses of US Congress.

FDA To Expand Postmarket Surveillance Of Medical Devices, Per GAO Report Requested By Lawmakers

 
• By Brian Bossetta

A government report requested by US lawmakers Debbie Dingell and Anna Eshoo to review the FDA’s postmarket surveillance of medical devices stresses that strengthening the system is critical to addressing adverse events linked to devices after they hit the market.

Legislation Could Bring Good News To Medicare Recipients With Severe Hearing Loss

 
• By Brian Bossetta

A bipartisan bill now in the US Senate seeks to change the classification of implantable hearing aid devices to allow Medicare to reimburse for the devices, potentially expanding access for many Americans who require them.

More from Policy & Regulation

News We’re Watching: New FDA Approvals For Breast Implant, Colon Cancer Test, Imaging Agent; TAP Expansion, AI Standards

This week, Establishment Labs Holdings announced the FDA gave it premarket approval for Motiva breast implant, Cologuard lands FDA approval for Cologuard Plus and GE HealthCare gets FDA nod for a new imaging agent. The FDA announces another expansion for TAP into ophthalmology and radiology. The AAMI and CTA will join forces to develop standards for AI and ML-enabled health care products.  

MI-PolicyAndRegulation (Free-1): Biliary Atresia Linked to Autism and Neurodevelopment Delays

 
• By Nabil

Children with biliary atresia (BA) exhibited neurodevelopmental deficits and increased autism traits, with earlier surgery linked to better general neurodevelopment.

Sponsored By

Nancy Tests SPARC-931 Part 7

This is a description